Protagen Oncimmune Buys Protagen for £4.1M The company said that it plans to use Protagen's assets to further the development and commercialization of its EarlyCDT cancer diagnostics. Protagen, NCT Heidelberg Partner to Predict Immunotherapy Response in Urothelial Cancer The project aims to identify biomarkers for predicting response and adverse events in urothelial carcinoma patients receiving immunotherapy. Protagen, NCT, NEC Partner on Prediction of Immunotherapy Response in Melanoma The parties will use machine learning to develop biomarker models for immunotherapy endpoints, including adverse effects, clinical response, and survival. Protagen Shifting to Focus on Cancer Immunotherapy Premium With a series of recent collaborations in hand, the company is leveraging its experience in autoimmune biomarkers to move into the immunoncology space. Protagen, Gustave Roussy Collaborating on Markers for Immunotherapy Side Effects Under the collaboration, they will use Protagen's SeroTag platform to test cancer immunotherapy patients for markers linked to immune-related adverse events. Feb 2, 2017 Protagen, NCI Partner to Identify Cancer Immunotherapy Biomarkers Jan 20, 2017 Immunovia's Blood-Based Array Test for Lupus Advances in New Study Premium Jan 17, 2017 Protagen, German Cancer Center Collaborate on Immunotherapy Biomarkers Aug 11, 2016 Protagen Licenses Systemic Sclerosis Marker to Inova Jun 15, 2016 Protagen Receives CE Mark for BICD2 Systemic Sclerosis Marker Mar 4, 2016 Protagen Using Protein Array Tech for Drug Target ID; Will Release Autoimmune Marker Panels Premium Feb 12, 2016 Researchers From Protagen, Targos, Elsewhere ID Protein Biomarkers for Prostate Inflammation Dec 11, 2015 Protagen Working With MATURA Consortium to Develop Proteomic Test to Predict Drug Response in RA Premium Nov 12, 2015 Protagen, Mikrogen Ink Lyme Disease Diagnostic Deal Jun 24, 2015 Protagen Obtains ISO Certification Dec 16, 2014 Protagen Closes First Part of Financing Round Nov 21, 2014 Qiagen Makes Move toward Proteomics with Protagen CDx Development Deal Premium Nov 17, 2014 Protagen, Qiagen Collaborate to Advance Development of Protein-based CDx for Autoimmune Diseases Sep 5, 2014 New Products: Biognosys, Protagen Premium Dec 3, 2013 Protagen Signs Biomarker Discovery Deal with Pfizer Jul 2, 2013 Protagen Sells Protein Services Subsidiary in Shift Toward Focus on Dx Development Mar 16, 2012 Protagen and NMI Collaborating on Protein Dx for Cancer and Autoimmune Diseases Premium Mar 16, 2012 Protagen, NMI Developing Assays for Autoimmune Diseases, Cancer Dec 7, 2011 Protagen, Bayer Partner on Biomarkers for Endometriosis Oct 28, 2011 Protagen, Charles River Ink Protein Analysis Services Alliance Load More Breaking News Roche Receives EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.